Business
Cytokinetics Announces Five Presentations at the 34th International Symposium on ALS/MND
Results from COURAGE-ALS to Be Presented on December 7, 2023 SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated
About this update from Cytokinetics, Incorporated
[{"type":"text","content":"Results from COURAGE-ALS to Be Presented on December 7, 2023\nSOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations at the 34th International Symposium on ALS/MND taking place in Basel, Switzerland and online from December 6, 2023 - December 8, 2023. Oral Presentations Title: Site and Participant Perspectives on Participating in an ALS Trial Designed to Reduce Burden: COURAGE-ALSPresenter: Stacy Rudnicki, M.D., Vice President, Clinical Research and Therapeutic Area Lead, Neuromuscular, CytokineticsDate: December 6, 2023Session Title: Session 3B: Technology and TelemedicineSession Time: 3:15-3:30 PM CETLocation: Singapore Title: COURAGE-ALS: Results of the Phase 3 Clinical Trial of Reldesemtiv in ALSPresenter: Jeremy M. Shefner, M.D., Ph.D., Professor of Neurology, Barrow Neurological Institute, University of Arizona College of Medicine Phoenix Date: December 7, 2023Session Title: Session 6B: Clinical TrialsSession Time: 10:30-10:50 AM CETLocation: Singapore Poster Presentations Title: Plasma Neurofilament Analysis in VITALITY-ALS: Analysis at Baseline, Longitudinal, and by Rate of Disease ProgressionPresenter: Tyrell Simpkins, D.O., Ph.D., Associate Medical Director, Clinical Research Neuromuscular, CytokineticsDate: December 6, 2023Session Title: Theme 10 – Disease Stratification and Phenotyping of Patient Poster Number: DSP-08Session Time: 6:45-7:45 PM CETLocation: Event Halle Title: Hospitalizations in COURAGE-ALS and Their Relationship to ALSPresenter: Stacy Rudnicki, M.D., Vice President, Clinical Research and Therapeutic Area Lead, Neuromuscular, CytokineticsDate: December 7, 2023Session Title: Theme 09 – Clinical Trials and Trial Design Poster Number: CLT-20Session Time: 5:45-6:45 PM CETLocation: Event Halle Title: Investigating Geographical Differences in Time from ALS Symptom Onset to Key Disease Milestones: Data from a Real-World SurveyPresenter: Paulos Gebrehiwet, Ph.D., M.S., Manager, Health Economics and Outcomes Research, CytokineticsDate: December 7, 2023Session Title: Theme 12 – Clinical Management and SupportPoster Number: CMS-53Session Time: 5:45-6:45 PM CETLocation: Event Halle About Cytokinetics Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commerciali...